Condition: Ischemic Stroke · Acute Stroke · Sponsor: Imperative Care, Inc.
This study is designed to evaluate the effectiveness, safety and clinical performance of ADAPT 2.0, first-line aspiration neurothrombectomy with Zoom System with Continuous Dual Aspiration Technique (CDAT).
This description comes directly from the study's public registry record.
Pojai Phattanagosai · 650-740-7703 · pphattanagosai@Imperativecare.com
Emma Pham · 408-421-7684 · epham@imperativecare.com
Always discuss trial participation with your own doctor first.
| Huntsville Hospital | Huntsville, Alabama, United States | Recruiting |
| John Muir Health | Walnut Creek, California, United States | Recruiting |
| University of South Florida | Tampa, Florida, United States | Recruiting |
| Ochsner Clinic Foundation | New Orleans, Louisiana, United States | Not Yet Recruiting |
| University of Maryland | Baltimore, Maryland, United States | Recruiting |
| Allina Health | Minneapolis, Minnesota, United States | Recruiting |
| Albany Medical College | Albany, New York, United States | Recruiting |
| Icahn School of Medicine at Mount Sinai | New York, New York, United States | Recruiting |
| Montefiore Medical Center | The Bronx, New York, United States | Not Yet Recruiting |
| University of Oklahoma, Health Science Center | Oklahoma City, Oklahoma, United States | Recruiting |
| Prisma Health - Upstate | Greenville, South Carolina, United States | Recruiting |
| Semmes Murphey Foundation | Memphis, Tennessee, United States | Recruiting |
+ 4 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07491952